An Example of Controversies on Anti-fibrosis Therapies in Cardiovascular Diseases: Transforming Growth Factor β1
*Corresponding Author
:
Masao Kakoki, Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, USA, Tel: 919 966 6915, Email: mkakoki@med.unc.edu
Received Date: Dec 14, 2015 / Accepted Date: Dec 14, 2015 / Published Date: Dec 29, 2015
Keywords: Transforming growth factor; hypomorphic mutations
Citation: Kakoki M (2015) An Example of Controversies on Anti-fibrosis Therapies in Cardiovascular Diseases: Transforming Growth Factor β1. Cardiovasc Ther 1: e101.
Copyright: © 2015 Kakoki M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Open Access Journals
Article Usage
- Total views: 10513
- [From(publication date): 2-2016 - Jul 18, 2024]
- Breakdown by view type
- HTML page views: 9798
- PDF downloads: 715
